Free Trial

PMV Pharmaceuticals (PMVP) Competitors

PMV Pharmaceuticals logo
$1.46 +0.08 (+5.43%)
As of 10:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PMVP vs. MREO, ABEO, CADL, DBVT, ALLO, EDIT, REPL, LYEL, KYTX, and TKNO

Should you be buying PMV Pharmaceuticals stock or one of its competitors? The main competitors of PMV Pharmaceuticals include Mereo BioPharma Group (MREO), Abeona Therapeutics (ABEO), Candel Therapeutics (CADL), DBV Technologies (DBVT), Allogene Therapeutics (ALLO), Editas Medicine (EDIT), Replimune Group (REPL), Lyell Immunopharma (LYEL), Kyverna Therapeutics (KYTX), and Alpha Teknova (TKNO). These companies are all part of the "pharmaceutical products" industry.

PMV Pharmaceuticals vs. Its Competitors

Mereo BioPharma Group (NASDAQ:MREO) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Mereo BioPharma Group has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500.

In the previous week, PMV Pharmaceuticals had 2 more articles in the media than Mereo BioPharma Group. MarketBeat recorded 3 mentions for PMV Pharmaceuticals and 1 mentions for Mereo BioPharma Group. Mereo BioPharma Group's average media sentiment score of 1.70 beat PMV Pharmaceuticals' score of 0.98 indicating that Mereo BioPharma Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mereo BioPharma Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
PMV Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

62.8% of Mereo BioPharma Group shares are owned by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are owned by institutional investors. 5.5% of Mereo BioPharma Group shares are owned by company insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

PMV Pharmaceuticals' return on equity of -47.94% beat Mereo BioPharma Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Mereo BioPharma GroupN/A -80.00% -66.94%
PMV Pharmaceuticals N/A -47.94%-43.82%

Mereo BioPharma Group currently has a consensus target price of $7.40, suggesting a potential upside of 303.27%. PMV Pharmaceuticals has a consensus target price of $5.50, suggesting a potential upside of 278.01%. Given Mereo BioPharma Group's stronger consensus rating and higher probable upside, research analysts clearly believe Mereo BioPharma Group is more favorable than PMV Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mereo BioPharma Group
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
PMV Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Mereo BioPharma Group has higher revenue and earnings than PMV Pharmaceuticals. Mereo BioPharma Group is trading at a lower price-to-earnings ratio than PMV Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mereo BioPharma Group$10M29.18-$43.25M-$0.07-26.21
PMV PharmaceuticalsN/AN/A-$58.71M-$1.57-0.93

Summary

Mereo BioPharma Group beats PMV Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

Get PMV Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PMVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PMVP vs. The Competition

MetricPMV PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$77.63M$2.54B$5.72B$10.39B
Dividend YieldN/A53.63%5.53%4.58%
P/E Ratio-0.9323.3076.1626.62
Price / SalesN/A519.56471.8492.08
Price / CashN/A171.0137.4661.85
Price / Book0.435.3813.336.46
Net Income-$58.71M$32.95M$3.29B$271.49M
7 Day Performance16.40%3.62%2.29%2.97%
1 Month Performance-1.69%5.55%4.44%7.56%
1 Year Performance-2.35%1.48%75.18%30.09%

PMV Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PMVP
PMV Pharmaceuticals
3.1052 of 5 stars
$1.46
+5.4%
$5.50
+278.0%
-7.4%$77.63MN/A-0.9350News Coverage
Analyst Revision
Gap Up
MREO
Mereo BioPharma Group
2.1696 of 5 stars
$1.85
+6.3%
$7.40
+300.0%
-56.0%$276.66M$10M-26.4340Positive News
ABEO
Abeona Therapeutics
4.0256 of 5 stars
$5.48
+1.9%
$19.50
+255.8%
-6.0%$275.88M$3.50M7.8390Positive News
CADL
Candel Therapeutics
2.7064 of 5 stars
$5.23
+8.7%
$20.00
+282.4%
-23.8%$264.05M$120K-7.5860Positive News
DBVT
DBV Technologies
2.8112 of 5 stars
$9.50
flat
$14.75
+55.3%
+167.1%$260.25M$4.15M-1.9980
ALLO
Allogene Therapeutics
3.1283 of 5 stars
$1.17
+0.9%
$8.44
+621.7%
-56.2%$257.38M$20K-1.05310Positive News
EDIT
Editas Medicine
3.8698 of 5 stars
$3.00
+6.0%
$5.10
+70.0%
-17.8%$254.47M$32.31M-1.05230
REPL
Replimune Group
4.5121 of 5 stars
$3.27
+1.6%
$6.50
+98.8%
-60.5%$251.73MN/A-1.01210Gap Down
LYEL
Lyell Immunopharma
1.7101 of 5 stars
$13.17
+0.6%
$15.00
+13.9%
-53.9%$251.48M$60K-0.54270High Trading Volume
KYTX
Kyverna Therapeutics
2.351 of 5 stars
$6.52
+12.4%
$16.60
+154.6%
+8.0%$250.82M$7.03M-1.7796News Coverage
High Trading Volume
TKNO
Alpha Teknova
2.0188 of 5 stars
$5.32
+14.7%
$10.00
+88.0%
+5.5%$248.31M$37.74M-12.67240High Trading Volume

Related Companies and Tools


This page (NASDAQ:PMVP) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners